The report "Gene Therapy Market By Vector Type (Adeno-associated Virus Vector, Lentiviral Vector, Herpes Virus Vector, Others), By Disease Type (Oncological, Disorders, Neurological Disorders, Rare Diseases, Others) - Global Forecasts to 2030"

The global gene therapy market is projected to reach USD 8.9 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 21.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the increasing regulatory approvals for gene therapy products.

Gene therapy is a medical approach that aims to treat or prevent disease by addressing the underlying genetic problem. Gene therapy treatments enable medical professionals to cure an issue by altering a person's genetic makeup rather than using medications or surgery. Gene therapy is being used to treat a small number of diseases, such as spinal muscular atrophy and Leber congenital amaurosis, which affect the muscles.

Request sample report at

Competitive Dashboard:
The prominent key players operating in the global Gene Therapy market are Amgen Inc., AnGes, Inc., Novartis AG, Kite Pharma (a subsidiary of Gilead Sciences, Inc.), uniQure NV, Oxford Biomedica, Spark Therapeutics, Inc., SIBONO, bluebird bio, Inc., Shanghai Sunway Biotech Co. Ltd., Biogen, Dendreon Pharmaceuticals LLC., and Enzyvant Therapeutics GmbHAudubon Bioscience

Regional Overview:
The report also examines the current concerns and their Future Effects on the Gene Therapy Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Gene Therapy Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

A Few Points from the Table of Contents –
1. Executive Summary
2. Global Gene Therapy Market Introduction
3. Global Gene Therapy Market Dynamics
4. Global Gene Therapy Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
9. Global Gene Therapy Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Gene Therapy Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Gene Therapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Gene Therapy Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations

Scope of The Report:

  • The gene therapy market research report includes historical data, trending features, and market growth estimates for the future.
  • The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
  • The gene therapy market report helps to provide the best results for business enhancement and business growth.
  • The report gives a comprehensive overview of both primary and secondary data.
  • The gene therapy market key players covered here to help them strengthen their place in the market.

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Mr. Satya
Precision Business Insights
 | Toll Free: +1 866 598 1553
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: | D U N S® Number: 852781747